Gregory Alan Korbel - Net Worth and Insider Trading
Gregory Alan Korbel Net Worth
The estimated net worth of Gregory Alan Korbel is at least $77,253 dollars as of 2024-06-09. Gregory Alan Korbel is the SVP, Chief Business Officer of Aprea Therapeutics Inc and owns about 17,167 shares of Aprea Therapeutics Inc (APRE) stock worth over $77,253. Details can be seen in Gregory Alan Korbel's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Gregory Alan Korbel has not made any transactions after 2021-12-01 and currently still holds the listed stock(s).
Transaction Summary of Gregory Alan Korbel
Gregory Alan Korbel Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gregory Alan Korbel owns 1 companies in total, including Aprea Therapeutics Inc (APRE) .
Click here to see the complete history of Gregory Alan Korbel’s form 4 insider trades.
Insider Ownership Summary of Gregory Alan Korbel
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| APRE | Aprea Therapeutics Inc | 2021-12-01 | Chief Business Officer |
Gregory Alan Korbel Latest Holdings Summary
Gregory Alan Korbel currently owns a total of 1 stock. Gregory Alan Korbel owns 17,167 shares of Aprea Therapeutics Inc (APRE) as of December 1, 2021, with a value of $77,253.
Latest Holdings of Gregory Alan Korbel
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| APRE | Aprea Therapeutics Inc | 2021-12-01 | 17,167 | 4.50 | 77,253 |
Holding Weightings of Gregory Alan Korbel
Gregory Alan Korbel Form 4 Trading Tracker
According to the SEC Form 4 filings, Gregory Alan Korbel has made a total of 5 transactions in Aprea Therapeutics Inc (APRE) over the past 5 years, including 1 buys and 4 sells. The most-recent trade in Aprea Therapeutics Inc is the sale of 27,500 shares on December 1, 2021, which brought Gregory Alan Korbel around $108,900.
Insider Trading History of Gregory Alan Korbel
- 1
Gregory Alan Korbel Trading Performance
GuruFocus tracks the stock performance after each of Gregory Alan Korbel's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gregory Alan Korbel is 115.11%. GuruFocus also compares Gregory Alan Korbel's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gregory Alan Korbel within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Gregory Alan Korbel's insider trading performs compared to the benchmark.
Performance of Gregory Alan Korbel
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 19.41 | | | | | |
| Relative Return to S&P 500(%) | 14.43 | | | | | |
Gregory Alan Korbel Ownership Network
Gregory Alan Korbel Owned Company Details
What does Aprea Therapeutics Inc do?
Who are the key executives at Aprea Therapeutics Inc?
Gregory Alan Korbel is the Chief Business Officer of Aprea Therapeutics Inc. Other key executives at Aprea Therapeutics Inc include President & CEO Oren Gilad , SrVP/CFO/Prin. Fin &Acctg. Off John P. Hamill , and director & President & CEO Christian S Schade .
Aprea Therapeutics Inc (APRE) Insider Trades Summary
Over the past 18 months, Gregory Alan Korbel made no insider transaction in Aprea Therapeutics Inc (APRE). Other recent insider transactions involving Aprea Therapeutics Inc (APRE) include a net purchase of 16,957 shares made by Bernd R. Seizinger , a net purchase of 6,860 shares made by Henneman John B Iii , and a net purchase of 2,000 shares made by Oren Gilad .
In summary, during the past 3 months, insiders sold 0 shares of Aprea Therapeutics Inc (APRE) in total and bought 16,730 shares, with a net purchase of 16,730 shares. During the past 18 months, 0 shares of Aprea Therapeutics Inc (APRE) were sold and 26,827 shares were bought by its insiders, resulting in a net purchase of 26,827 shares.
Aprea Therapeutics Inc (APRE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aprea Therapeutics Inc Insider Transactions
Gregory Alan Korbel Mailing Address
Above is the net worth, insider trading, and ownership report for Gregory Alan Korbel. You might contact Gregory Alan Korbel via mailing address: 535 Boylston Street, Boston Ma 02116.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
